Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
about
The CK1 Family: Contribution to Cellular Stress Response and Its Role in CarcinogenesisCrystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressorMyosin VI is a mediator of the p53-dependent cell survival pathway.Inhibition of p53 DNA binding by human papillomavirus E6 proteinsRepression of p53-mediated transcription by MDM2: a dual mechanismSequential binding of UV DNA damage binding factor and degradation of the p48 subunit as early events after UV irradiation.p53 Stimulates TFIID-TFIIA-promoter complex assembly, and p53-T antigen complex inhibits TATA binding protein-TATA interactionp53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent mannerRegulation of apoptosis by viral gene productsMicrobial Regulation of p53 Tumor SuppressorHuman securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosisGrowth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinomaReactive oxygen species mediate Cr(VI)-induced carcinogenesis through PI3K/AKT-dependent activation of GSK-3β/β-catenin signalingMapping of the p53 and mdm-2 interaction domainsThe dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA bindingDegradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complexInteraction between the HPV-16 E2 transcriptional activator and p53.Analysis of a protein-binding domain of p53Simian virus 40 T antigen can regulate p53-mediated transcription independent of binding p53.Design of a single plasmid-based modified yeast one-hybrid system for investigation of in vivo protein-protein and protein-DNA interactionsThe emerging p53 gene family.The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators.Role of human cytomegalovirus immediate-early proteins in cell growth control.Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53.Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA.Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathwaysRole of Stat3 in regulating p53 expression and functionNew insights into the mechanism of inhibition of p53 by simian virus 40 large T antigenAL1-dependent repression of transcription enhances expression of Tomato golden mosaic virus AL2 and AL3.Noninvasive imaging of protein-protein interactions in living animalsInduction and bypass of p53 during productive infection by polyomavirusLarge T and small T antigens of Merkel cell polyomavirus.Altered expression of Arabidopsis genes in response to a multifunctional geminivirus pathogenicity protein.An anticlastogenic function for the Polycomb Group gene Bmi1.Simian virus 40 large T antigen and two independent T-antigen segments sensitize cells to apoptosis following genotoxic damageMapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics.Polyomavirus T antigens activate an antiviral state.Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4.Baculovirus infection induces a DNA damage response that is required for efficient viral replication.
P2860
Q21129297-BE371F35-536D-408D-B3BD-FD26A5CEB21DQ24301537-88A86CC0-7191-4E5B-8951-58200D10E1C2Q24306104-6B2E4E75-634D-4544-9D58-52E644CFFC58Q24317013-3AEBBE69-6F79-4105-B150-1B4B5E58CB59Q24336020-38B2FB43-4435-416E-A303-F08E121EC49CQ24530000-B345098B-021A-41AF-BAE4-6FF47774915AQ24550965-20DF6D14-23CE-4818-B76D-EF9AC76D821BQ24643993-6D5264E5-4106-4590-A749-4920C7ED19C5Q24678703-064C7B2B-B3B1-426D-9075-8409EC0B65E2Q26785743-20D15A51-56CB-4F82-8FAF-2140CA92A9DCQ28204629-B2ECE587-95B4-4B98-8883-11EE45D6056FQ28295550-1BBE641C-9947-467B-9547-57F1D0287C92Q28387227-E32A90CC-AC39-4A45-B0D9-5BE2C28DBBBDQ28609886-9AB8E585-0466-4C5E-96AA-347BA412140CQ28639955-28F6F7B7-35D6-4EFD-B2A2-BC008EE1C957Q29041391-0BE642F3-D4B8-4897-B943-A5A6649755BDQ33292209-2B592132-51B2-4309-98F8-A33F34E78F5BQ33292314-49D5D94A-7E78-49E0-A581-3FE3651EC996Q33292433-5BCB15E8-9304-4C97-9E04-BC29F081042CQ33367734-621FADE2-96F6-4ABC-94A8-3B47FCF19F60Q33593937-E1361145-09D9-4CBE-B242-A7028F1FFBE5Q33648852-9A8E567B-7BB4-4EE0-9278-6BB4053F0923Q33737277-AECE7B76-8A70-494B-87C0-D47BC864C7B6Q33810785-4869061F-5885-401D-85BB-6257D5A0C1B6Q33843097-739B0EC9-C975-4797-9771-C4E708F04B5BQ33912006-E9545997-E44C-47F5-BD08-780CD85B1066Q33916804-BC543382-4392-49EA-B5C6-35BC9713DD47Q33925115-47A8AFAF-E386-4684-BBDD-20A436616942Q33957704-CAF99F6D-1735-4928-A272-29DE22707F7EQ33985318-1E78E79B-4206-473E-85D5-BF2C9C8B4E0CQ34068030-F74F6CD7-A9DF-4160-9113-A47B100BCEBDQ34344606-F110125B-274F-41A7-8D87-A9FDFE75FFF3Q34462768-0E704723-12B4-4E7D-9F4B-F910DCC5F84BQ34620202-1FEEC7C0-FBF1-4BCF-A85D-4E6F4878C22FQ34750024-172B622E-4F97-47ED-AFF0-A402465F9E8EQ35000664-05255CC8-1A16-4A1E-A7CD-17FFB27BFAADQ35063635-4085C13B-D9CD-4B01-9DEF-1095CAB17499Q35070008-63B15957-DFD2-4645-98B7-7B13664CECD2Q35212701-CDC8CAC0-30B9-485E-80FC-4CBF002568DFQ35531444-88CB395E-8D88-435E-B0EF-CC381867B7B3
P2860
Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Site-specific binding of wild- ...... SV40 T antigen and mutant p53.
@en
type
label
Site-specific binding of wild- ...... SV40 T antigen and mutant p53.
@en
prefLabel
Site-specific binding of wild- ...... SV40 T antigen and mutant p53.
@en
P2093
P356
P1433
P1476
Site-specific binding of wild- ...... SV40 T antigen and mutant p53.
@en
P2093
Bargonetti J
Friedman PN
Reynisdóttir I
P304
P356
10.1101/GAD.6.10.1886
P577
1992-10-01T00:00:00Z